To examine the therapeutic effects of ACE2-MSCs on COVID-19, we overexpressed ACE2 in hUC-MSCs (ACE2-MSCs) and used the empty vector as a control (GFP-MSCs) (Figure 3A). This evidence concerns the gene ACE2 and COVID-19.